Trevi Therapeutics, a clinical-stage biopharmaceutical company, announced its senior management will participate in several upcoming events including the Needham Virtual Healthcare Conference (April 13-16), Raymond James Biotech Innovation Symposium (April 14), Oppenheimer’s Innovation on the Island (April 27-29), and its own Investor and Analyst Day on May 7, 2026. The company is developing Haduvio™, an investigational oral therapy for chronic cough in patients with idiopathic pulmonary fibrosis, non-IPF interstitial lung disease, and refractory chronic cough. These events provide opportunities to update investors and analysts on clinical progress and the potential impact of Haduvio, which addresses a significant unmet medical need with no current FDA-approved treatments. Trevi aims to advance Haduvio through late-stage trials and regulatory review.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Rotork PLC has accepted a £4.1 billion takeover bid from Swiss engineering group ABB, offering shareholders 506p per share, a 73% premium over the previous closing price. The acquisition will enhance ABB's industrial automation business by adding Rot...
Alexandria Real Estate Equities (ARE) is struggling with oversupply and vacancy rates exceeding 30% in key life science markets like Boston, San Francisco, and San Diego. This has caused an 80% decline in its stock price from its peak. The company's ...
ASML Holdings has raised its 2026 revenue guidance midpoint from €38 billion to €44 billion and increased its gross margin midpoint from 52% to 55%, reflecting strong growth prospects. The analyst maintains a Buy rating and raises the price target fr...
Labcorp is considered a buy due to its effective rollup strategy in a fragmented lab testing industry, driving steady and predictable growth. Automation is reducing operational costs, helping to counteract healthcare pricing pressures. The company no...
